DENISE SPEICH: Open Payments
NPI 1023160447 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 68 payments from 16 companies in 2025. Trend: 2023 $1,062 · 2024 $1,577 · 2025 $1,065
Food & beverage: $1,056Education: $9
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $258 |
| Celltrion USA Inc. | 5 | $180 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $154 |
| ABBVIE INC. | 12 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Madrigal Pharmaceuticals | 2 | $42 |
| QOL Medical, LLC | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $27 |
| GENZYME CORPORATION | 1 | $22 |
Products named: TREMFYA, ENTYVIO, ZYMFENTRA, RINVOQ, XIFAXAN, VEGZELMA, REZDIFFRA, Sucraid.
Industry payments across NE — which companies pay providers there.
